APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dexlansoprazole Delayed-Release Capsules

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dexlansoprazole Delayed-Release Capsules Market Analysis and Forecast 2026-2032

30 December 2025199 pages

Choose your research edition.

Industry ResearchDexlansoprazole Delayed-Release Capsules Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Dexlansoprazole Delayed-Release Capsules Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Dexlansoprazole Delayed-Release Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dexlansoprazole Delayed-Release Capsules Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Dexlansoprazole Delayed-Release Capsules Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Dexlansoprazole Delayed-Release Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dexlansoprazole Delayed-Release Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dexlansoprazole Delayed-Release Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dexlansoprazole Delayed-Release Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dexlansoprazole Delayed-Release Capsules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dexlansoprazole Delayed-Release Capsules include Takeda Pharmaceuticals, Viatris, TWi Pharmaceuticals and Endo, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dexlansoprazole Delayed-Release Capsules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dexlansoprazole Delayed-Release Capsules, also provides the sales of main regions and countries. Of the upcoming market potential for Dexlansoprazole Delayed-Release Capsules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dexlansoprazole Delayed-Release Capsules sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dexlansoprazole Delayed-Release Capsules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dexlansoprazole Delayed-Release Capsules sales, projected growth trends, production technology, application and end-user industry.

Dexlansoprazole Delayed-Release Capsules Segment by Company

Takeda Pharmaceuticals

Viatris

TWi Pharmaceuticals

Endo

Dexlansoprazole Delayed-Release Capsules Segment by Type

30mg

60mg

Dexlansoprazole Delayed-Release Capsules Segment by Application

Hospital

Clinic

Others

Dexlansoprazole Delayed-Release Capsules Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dexlansoprazole Delayed-Release Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dexlansoprazole Delayed-Release Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dexlansoprazole Delayed-Release Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dexlansoprazole Delayed-Release Capsules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dexlansoprazole Delayed-Release Capsules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dexlansoprazole Delayed-Release Capsules sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dexlansoprazole Delayed-Release Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 30mg Major Manufacturers Table 3. 60mg Major Manufacturers Table 4. Global Dexlansoprazole Delayed-Release Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Others Major Manufacturers Table 8. Dexlansoprazole Delayed-Release Capsules Industry Trends Table 9. Dexlansoprazole Delayed-Release Capsules Industry Drivers Table 10. Dexlansoprazole Delayed-Release Capsules Industry Opportunities and Challenges Table 11. Dexlansoprazole Delayed-Release Capsules Industry Restraints Table 12. Global Dexlansoprazole Delayed-Release Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Dexlansoprazole Delayed-Release Capsules Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Dexlansoprazole Delayed-Release Capsules Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Region (2021-2026) Table 16. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Region (2027-2032) Table 17. Global Dexlansoprazole Delayed-Release Capsules Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Dexlansoprazole Delayed-Release Capsules Sales by Region (2021-2026) & (K Units) Table 19. Global Dexlansoprazole Delayed-Release Capsules Sales by Region (2027-2032) & (K Units) Table 20. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Region (2021-2026) Table 21. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Region (2027-2032) Table 22. Global Dexlansoprazole Delayed-Release Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Dexlansoprazole Delayed-Release Capsules Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Manufacturers (2021-2026) Table 26. Global Dexlansoprazole Delayed-Release Capsules Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Dexlansoprazole Delayed-Release Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Dexlansoprazole Delayed-Release Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Dexlansoprazole Delayed-Release Capsules Manufacturers, Product Type & Application Table 30. Global Dexlansoprazole Delayed-Release Capsules Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Dexlansoprazole Delayed-Release Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Dexlansoprazole Delayed-Release Capsules Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Dexlansoprazole Delayed-Release Capsules Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Dexlansoprazole Delayed-Release Capsules Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Type (2021-2026) Table 37. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Type (2027-2032) Table 38. Global Dexlansoprazole Delayed-Release Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Dexlansoprazole Delayed-Release Capsules Sales by Type (2021-2026) & (K Units) Table 40. Global Dexlansoprazole Delayed-Release Capsules Sales by Type (2027-2032) & (K Units) Table 41. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Type (2021-2026) Table 42. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Type (2027-2032) Table 43. Global Dexlansoprazole Delayed-Release Capsules Price by Type (2021-2026) & (US$/Unit) Table 44. Global Dexlansoprazole Delayed-Release Capsules Price by Type (2027-2032) & (US$/Unit) Table 45. Global Dexlansoprazole Delayed-Release Capsules Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Dexlansoprazole Delayed-Release Capsules Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Dexlansoprazole Delayed-Release Capsules Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Application (2021-2026) Table 49. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Application (2027-2032) Table 50. Global Dexlansoprazole Delayed-Release Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Dexlansoprazole Delayed-Release Capsules Sales by Application (2021-2026) & (K Units) Table 52. Global Dexlansoprazole Delayed-Release Capsules Sales by Application (2027-2032) & (K Units) Table 53. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Application (2021-2026) Table 54. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Application (2027-2032) Table 55. Global Dexlansoprazole Delayed-Release Capsules Price by Application (2021-2026) & (US$/Unit) Table 56. Global Dexlansoprazole Delayed-Release Capsules Price by Application (2027-2032) & (US$/Unit) Table 57. Takeda Pharmaceuticals Company Information Table 58. Takeda Pharmaceuticals Business Overview Table 59. Takeda Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Takeda Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Product Portfolio Table 61. Takeda Pharmaceuticals Recent Development Table 62. Viatris Company Information Table 63. Viatris Business Overview Table 64. Viatris Dexlansoprazole Delayed-Release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Viatris Dexlansoprazole Delayed-Release Capsules Product Portfolio Table 66. Viatris Recent Development Table 67. TWi Pharmaceuticals Company Information Table 68. TWi Pharmaceuticals Business Overview Table 69. TWi Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. TWi Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Product Portfolio Table 71. TWi Pharmaceuticals Recent Development Table 72. Endo Company Information Table 73. Endo Business Overview Table 74. Endo Dexlansoprazole Delayed-Release Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Endo Dexlansoprazole Delayed-Release Capsules Product Portfolio Table 76. Endo Recent Development Table 77. North America Dexlansoprazole Delayed-Release Capsules Revenue by Type (2021-2026) & (US$ Million) Table 78. North America Dexlansoprazole Delayed-Release Capsules Revenue by Type (2027-2032) & (US$ Million) Table 79. North America Dexlansoprazole Delayed-Release Capsules Sales by Type (2021-2026) & (K Units) Table 80. North America Dexlansoprazole Delayed-Release Capsules Sales by Type (2027-2032) & (K Units) Table 81. North America Dexlansoprazole Delayed-Release Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 82. North America Dexlansoprazole Delayed-Release Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 83. North America Dexlansoprazole Delayed-Release Capsules Revenue by Application (2021-2026) & (US$ Million) Table 84. North America Dexlansoprazole Delayed-Release Capsules Revenue by Application (2027-2032) & (US$ Million) Table 85. North America Dexlansoprazole Delayed-Release Capsules Sales by Application (2021-2026) & (K Units) Table 86. North America Dexlansoprazole Delayed-Release Capsules Sales by Application (2027-2032) & (K Units) Table 87. North America Dexlansoprazole Delayed-Release Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 88. North America Dexlansoprazole Delayed-Release Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 89. North America Dexlansoprazole Delayed-Release Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Dexlansoprazole Delayed-Release Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 91. North America Dexlansoprazole Delayed-Release Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 92. North America Dexlansoprazole Delayed-Release Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 93. North America Dexlansoprazole Delayed-Release Capsules Sales by Country (2021-2026) & (K Units) Table 94. North America Dexlansoprazole Delayed-Release Capsules Sales by Country (2027-2032) & (K Units) Table 95. North America Dexlansoprazole Delayed-Release Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 96. North America Dexlansoprazole Delayed-Release Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 97. United States Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 98. Canada Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 99. Europe Dexlansoprazole Delayed-Release Capsules Revenue by Type (2021-2026) & (US$ Million) Table 100. Europe Dexlansoprazole Delayed-Release Capsules Revenue by Type (2027-2032) & (US$ Million) Table 101. Europe Dexlansoprazole Delayed-Release Capsules Sales by Type (2021-2026) & (K Units) Table 102. Europe Dexlansoprazole Delayed-Release Capsules Sales by Type (2027-2032) & (K Units) Table 103. Europe Dexlansoprazole Delayed-Release Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 104. Europe Dexlansoprazole Delayed-Release Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 105. Europe Dexlansoprazole Delayed-Release Capsules Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Dexlansoprazole Delayed-Release Capsules Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Dexlansoprazole Delayed-Release Capsules Sales by Application (2021-2026) & (K Units) Table 108. Europe Dexlansoprazole Delayed-Release Capsules Sales by Application (2027-2032) & (K Units) Table 109. Europe Dexlansoprazole Delayed-Release Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 110. Europe Dexlansoprazole Delayed-Release Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 111. Europe Dexlansoprazole Delayed-Release Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Dexlansoprazole Delayed-Release Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. Europe Dexlansoprazole Delayed-Release Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. Europe Dexlansoprazole Delayed-Release Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 115. Europe Dexlansoprazole Delayed-Release Capsules Sales by Country (2021-2026) & (K Units) Table 116. Europe Dexlansoprazole Delayed-Release Capsules Sales by Country (2027-2032) & (K Units) Table 117. Europe Dexlansoprazole Delayed-Release Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 118. Europe Dexlansoprazole Delayed-Release Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 119. Germany Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 120. France Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 121. U.K. Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 122. Italy Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 123. Netherlands Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 124. China Dexlansoprazole Delayed-Release Capsules Revenue by Type (2021-2026) & (US$ Million) Table 125. China Dexlansoprazole Delayed-Release Capsules Revenue by Type (2027-2032) & (US$ Million) Table 126. China Dexlansoprazole Delayed-Release Capsules Sales by Type (2021-2026) & (K Units) Table 127. China Dexlansoprazole Delayed-Release Capsules Sales by Type (2027-2032) & (K Units) Table 128. China Dexlansoprazole Delayed-Release Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 129. China Dexlansoprazole Delayed-Release Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 130. China Dexlansoprazole Delayed-Release Capsules Revenue by Application (2021-2026) & (US$ Million) Table 131. China Dexlansoprazole Delayed-Release Capsules Revenue by Application (2027-2032) & (US$ Million) Table 132. China Dexlansoprazole Delayed-Release Capsules Sales by Application (2021-2026) & (K Units) Table 133. China Dexlansoprazole Delayed-Release Capsules Sales by Application (2027-2032) & (K Units) Table 134. China Dexlansoprazole Delayed-Release Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 135. China Dexlansoprazole Delayed-Release Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 136. Asia Dexlansoprazole Delayed-Release Capsules Revenue by Type (2021-2026) & (US$ Million) Table 137. Asia Dexlansoprazole Delayed-Release Capsules Revenue by Type (2027-2032) & (US$ Million) Table 138. Asia Dexlansoprazole Delayed-Release Capsules Sales by Type (2021-2026) & (K Units) Table 139. Asia Dexlansoprazole Delayed-Release Capsules Sales by Type (2027-2032) & (K Units) Table 140. Asia Dexlansoprazole Delayed-Release Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 141. Asia Dexlansoprazole Delayed-Release Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 142. Asia Dexlansoprazole Delayed-Release Capsules Revenue by Application (2021-2026) & (US$ Million) Table 143. Asia Dexlansoprazole Delayed-Release Capsules Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia Dexlansoprazole Delayed-Release Capsules Sales by Application (2021-2026) & (K Units) Table 145. Asia Dexlansoprazole Delayed-Release Capsules Sales by Application (2027-2032) & (K Units) Table 146. Asia Dexlansoprazole Delayed-Release Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 147. Asia Dexlansoprazole Delayed-Release Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 148. Asia Dexlansoprazole Delayed-Release Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Asia Dexlansoprazole Delayed-Release Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Asia Dexlansoprazole Delayed-Release Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Asia Dexlansoprazole Delayed-Release Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 152. Asia Dexlansoprazole Delayed-Release Capsules Sales by Country (2021-2026) & (K Units) Table 153. Asia Dexlansoprazole Delayed-Release Capsules Sales by Country (2027-2032) & (K Units) Table 154. Asia Dexlansoprazole Delayed-Release Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 155. Asia Dexlansoprazole Delayed-Release Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 156. Japan Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 157. South Korea Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 158. India Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 159. Australia Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 160. China Taiwan Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 161. Southeast Asia Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 162. SAMEA Dexlansoprazole Delayed-Release Capsules Revenue by Type (2021-2026) & (US$ Million) Table 163. SAMEA Dexlansoprazole Delayed-Release Capsules Revenue by Type (2027-2032) & (US$ Million) Table 164. SAMEA Dexlansoprazole Delayed-Release Capsules Sales by Type (2021-2026) & (K Units) Table 165. SAMEA Dexlansoprazole Delayed-Release Capsules Sales by Type (2027-2032) & (K Units) Table 166. SAMEA Dexlansoprazole Delayed-Release Capsules Sales Price by Type (2021-2026) & (US$/Unit) Table 167. SAMEA Dexlansoprazole Delayed-Release Capsules Sales Price by Type (2027-2032) & (US$/Unit) Table 168. SAMEA Dexlansoprazole Delayed-Release Capsules Revenue by Application (2021-2026) & (US$ Million) Table 169. SAMEA Dexlansoprazole Delayed-Release Capsules Revenue by Application (2027-2032) & (US$ Million) Table 170. SAMEA Dexlansoprazole Delayed-Release Capsules Sales by Application (2021-2026) & (K Units) Table 171. SAMEA Dexlansoprazole Delayed-Release Capsules Sales by Application (2027-2032) & (K Units) Table 172. SAMEA Dexlansoprazole Delayed-Release Capsules Sales Price by Application (2021-2026) & (US$/Unit) Table 173. SAMEA Dexlansoprazole Delayed-Release Capsules Sales Price by Application (2027-2032) & (US$/Unit) Table 174. SAMEA Dexlansoprazole Delayed-Release Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. SAMEA Dexlansoprazole Delayed-Release Capsules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. SAMEA Dexlansoprazole Delayed-Release Capsules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. SAMEA Dexlansoprazole Delayed-Release Capsules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 178. SAMEA Dexlansoprazole Delayed-Release Capsules Sales by Country (2021-2026) & (K Units) Table 179. SAMEA Dexlansoprazole Delayed-Release Capsules Sales by Country (2027-2032) & (K Units) Table 180. SAMEA Dexlansoprazole Delayed-Release Capsules Sales Price by Country (2021-2026) & (US$/Unit) Table 181. SAMEA Dexlansoprazole Delayed-Release Capsules Sales Price by Country (2027-2032) & (US$/Unit) Table 182. Brazil Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 183. Argentina Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 184. Chile Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 185. Colombia Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 186. Peru Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 187. Saudi Arabia Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 188. Israel Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 189. UAE Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 190. Turkey Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 191. Iran Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 192. Egypt Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. Dexlansoprazole Delayed-Release Capsules Distributors List Table 196. Dexlansoprazole Delayed-Release Capsules Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Dexlansoprazole Delayed-Release Capsules Image Figure 2. Global Dexlansoprazole Delayed-Release Capsules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dexlansoprazole Delayed-Release Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 4. 30mg Image Figure 5. 60mg Image Figure 6. Global Dexlansoprazole Delayed-Release Capsules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Dexlansoprazole Delayed-Release Capsules Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Dexlansoprazole Delayed-Release Capsules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Dexlansoprazole Delayed-Release Capsules Revenue (2021-2032) & (US$ Million) Figure 13. Global Dexlansoprazole Delayed-Release Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Region (2021-2032) Figure 16. Global Dexlansoprazole Delayed-Release Capsules Sales (2021-2032) & (K Units) Figure 17. Global Dexlansoprazole Delayed-Release Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Dexlansoprazole Delayed-Release Capsules Sales YoY (2021-2032) & (K Units) Figure 20. Europe Dexlansoprazole Delayed-Release Capsules Sales YoY (2021-2032) & (K Units) Figure 21. China Dexlansoprazole Delayed-Release Capsules Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Dexlansoprazole Delayed-Release Capsules Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Dexlansoprazole Delayed-Release Capsules Sales YoY (2021-2032) & (K Units) Figure 24. Global Dexlansoprazole Delayed-Release Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Dexlansoprazole Delayed-Release Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Dexlansoprazole Delayed-Release Capsules Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Type (2021-2032) Figure 30. Global Dexlansoprazole Delayed-Release Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Type (2021-2032) Figure 33. Global Dexlansoprazole Delayed-Release Capsules Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Application (2021-2032) Figure 36. Global Dexlansoprazole Delayed-Release Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Application (2021-2032) Figure 39. North America Dexlansoprazole Delayed-Release Capsules Revenue Share by Type (2021-2032) Figure 40. North America Dexlansoprazole Delayed-Release Capsules Sales Share by Type (2021-2032) Figure 41. North America Dexlansoprazole Delayed-Release Capsules Revenue Share by Application (2021-2032) Figure 42. North America Dexlansoprazole Delayed-Release Capsules Sales Share by Application (2021-2032) Figure 43. North America Dexlansoprazole Delayed-Release Capsules Revenue Share by Country (2021-2032) Figure 44. North America Dexlansoprazole Delayed-Release Capsules Sales Share by Country (2021-2032) Figure 45. Europe Dexlansoprazole Delayed-Release Capsules Revenue Share by Type (2021-2032) Figure 46. Europe Dexlansoprazole Delayed-Release Capsules Sales Share by Type (2021-2032) Figure 47. Europe Dexlansoprazole Delayed-Release Capsules Revenue Share by Application (2021-2032) Figure 48. Europe Dexlansoprazole Delayed-Release Capsules Sales Share by Application (2021-2032) Figure 49. Europe Dexlansoprazole Delayed-Release Capsules Revenue Share by Country (2021-2032) Figure 50. Europe Dexlansoprazole Delayed-Release Capsules Sales Share by Country (2021-2032) Figure 51. China Dexlansoprazole Delayed-Release Capsules Revenue Share by Type (2021-2032) Figure 52. China Dexlansoprazole Delayed-Release Capsules Sales Share by Type (2021-2032) Figure 53. China Dexlansoprazole Delayed-Release Capsules Revenue Share by Application (2021-2032) Figure 54. China Dexlansoprazole Delayed-Release Capsules Sales Share by Application (2021-2032) Figure 55. Asia Dexlansoprazole Delayed-Release Capsules Revenue Share by Type (2021-2032) Figure 56. Asia Dexlansoprazole Delayed-Release Capsules Sales Share by Type (2021-2032) Figure 57. Asia Dexlansoprazole Delayed-Release Capsules Revenue Share by Application (2021-2032) Figure 58. Asia Dexlansoprazole Delayed-Release Capsules Sales Share by Application (2021-2032) Figure 59. Asia Dexlansoprazole Delayed-Release Capsules Revenue Share by Country (2021-2032) Figure 60. Asia Dexlansoprazole Delayed-Release Capsules Sales Share by Country (2021-2032) Figure 61. SAMEA Dexlansoprazole Delayed-Release Capsules Revenue Share by Type (2021-2032) Figure 62. SAMEA Dexlansoprazole Delayed-Release Capsules Sales Share by Type (2021-2032) Figure 63. SAMEA Dexlansoprazole Delayed-Release Capsules Revenue Share by Application (2021-2032) Figure 64. SAMEA Dexlansoprazole Delayed-Release Capsules Sales Share by Application (2021-2032) Figure 65. SAMEA Dexlansoprazole Delayed-Release Capsules Revenue Share by Country (2021-2032) Figure 66. SAMEA Dexlansoprazole Delayed-Release Capsules Sales Share by Country (2021-2032) Figure 67. Dexlansoprazole Delayed-Release Capsules Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Dexlansoprazole Delayed-Release Capsules Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 30mg
  • 60mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Takeda Pharmaceuticals
  • Viatris
  • TWi Pharmaceuticals
  • Endo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dexlansoprazole Delayed-Release Capsules Market by Type
  3. 1.2.1 Global Dexlansoprazole Delayed-Release Capsules Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 30mg
  5. 1.2.3 60mg
  6. 1.3 Dexlansoprazole Delayed-Release Capsules Market by Application
  7. 1.3.1 Global Dexlansoprazole Delayed-Release Capsules Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Dexlansoprazole Delayed-Release Capsules Market Dynamics
  1. 2.1 Dexlansoprazole Delayed-Release Capsules Industry Trends
  2. 2.2 Dexlansoprazole Delayed-Release Capsules Industry Drivers
  3. 2.3 Dexlansoprazole Delayed-Release Capsules Industry Opportunities and Challenges
  4. 2.4 Dexlansoprazole Delayed-Release Capsules Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dexlansoprazole Delayed-Release Capsules Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dexlansoprazole Delayed-Release Capsules Revenue by Region
  3. 3.2.1 Global Dexlansoprazole Delayed-Release Capsules Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dexlansoprazole Delayed-Release Capsules Revenue by Region (2021-2026)
  5. 3.2.3 Global Dexlansoprazole Delayed-Release Capsules Revenue by Region (2027-2032)
  6. 3.2.4 Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dexlansoprazole Delayed-Release Capsules Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dexlansoprazole Delayed-Release Capsules Sales by Region
  9. 3.4.1 Global Dexlansoprazole Delayed-Release Capsules Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dexlansoprazole Delayed-Release Capsules Sales by Region (2021-2026)
  11. 3.4.3 Global Dexlansoprazole Delayed-Release Capsules Sales by Region (2027-2032)
  12. 3.4.4 Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dexlansoprazole Delayed-Release Capsules Revenue by Manufacturers
  2. 4.1.1 Global Dexlansoprazole Delayed-Release Capsules Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dexlansoprazole Delayed-Release Capsules Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dexlansoprazole Delayed-Release Capsules Sales by Manufacturers
  6. 4.2.1 Global Dexlansoprazole Delayed-Release Capsules Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dexlansoprazole Delayed-Release Capsules Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dexlansoprazole Delayed-Release Capsules Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dexlansoprazole Delayed-Release Capsules Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dexlansoprazole Delayed-Release Capsules Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dexlansoprazole Delayed-Release Capsules Manufacturers, Product Type & Application
  13. 4.7 Global Dexlansoprazole Delayed-Release Capsules Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dexlansoprazole Delayed-Release Capsules Market CR5 and HHI
  16. 4.8.2 2025 Dexlansoprazole Delayed-Release Capsules Tier 1, Tier 2, and Tier 3
5 Dexlansoprazole Delayed-Release Capsules Market by Type
  1. 5.1 Global Dexlansoprazole Delayed-Release Capsules Revenue by Type
  2. 5.1.1 Global Dexlansoprazole Delayed-Release Capsules Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dexlansoprazole Delayed-Release Capsules Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dexlansoprazole Delayed-Release Capsules Sales by Type
  6. 5.2.1 Global Dexlansoprazole Delayed-Release Capsules Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dexlansoprazole Delayed-Release Capsules Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dexlansoprazole Delayed-Release Capsules Price by Type
6 Dexlansoprazole Delayed-Release Capsules Market by Application
  1. 6.1 Global Dexlansoprazole Delayed-Release Capsules Revenue by Application
  2. 6.1.1 Global Dexlansoprazole Delayed-Release Capsules Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dexlansoprazole Delayed-Release Capsules Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dexlansoprazole Delayed-Release Capsules Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dexlansoprazole Delayed-Release Capsules Sales by Application
  6. 6.2.1 Global Dexlansoprazole Delayed-Release Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dexlansoprazole Delayed-Release Capsules Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Dexlansoprazole Delayed-Release Capsules Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dexlansoprazole Delayed-Release Capsules Price by Application
7 Company Profiles
  1. 7.1 Takeda Pharmaceuticals
  2. 7.1.1 Takeda Pharmaceuticals Company Information
  3. 7.1.2 Takeda Pharmaceuticals Business Overview
  4. 7.1.3 Takeda Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Product Portfolio
  6. 7.1.5 Takeda Pharmaceuticals Recent Developments
  7. 7.2 Viatris
  8. 7.2.1 Viatris Company Information
  9. 7.2.2 Viatris Business Overview
  10. 7.2.3 Viatris Dexlansoprazole Delayed-Release Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Viatris Dexlansoprazole Delayed-Release Capsules Product Portfolio
  12. 7.2.5 Viatris Recent Developments
  13. 7.3 TWi Pharmaceuticals
  14. 7.3.1 TWi Pharmaceuticals Company Information
  15. 7.3.2 TWi Pharmaceuticals Business Overview
  16. 7.3.3 TWi Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 TWi Pharmaceuticals Dexlansoprazole Delayed-Release Capsules Product Portfolio
  18. 7.3.5 TWi Pharmaceuticals Recent Developments
  19. 7.4 Endo
  20. 7.4.1 Endo Company Information
  21. 7.4.2 Endo Business Overview
  22. 7.4.3 Endo Dexlansoprazole Delayed-Release Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Endo Dexlansoprazole Delayed-Release Capsules Product Portfolio
  24. 7.4.5 Endo Recent Developments
8 North America
  1. 8.1 North America Dexlansoprazole Delayed-Release Capsules Market Size by Type
  2. 8.1.1 North America Dexlansoprazole Delayed-Release Capsules Revenue by Type (2021-2032)
  3. 8.1.2 North America Dexlansoprazole Delayed-Release Capsules Sales by Type (2021-2032)
  4. 8.1.3 North America Dexlansoprazole Delayed-Release Capsules Price by Type (2021-2032)
  5. 8.2 North America Dexlansoprazole Delayed-Release Capsules Market Size by Application
  6. 8.2.1 North America Dexlansoprazole Delayed-Release Capsules Revenue by Application (2021-2032)
  7. 8.2.2 North America Dexlansoprazole Delayed-Release Capsules Sales by Application (2021-2032)
  8. 8.2.3 North America Dexlansoprazole Delayed-Release Capsules Price by Application (2021-2032)
  9. 8.3 North America Dexlansoprazole Delayed-Release Capsules Market Size by Country
  10. 8.3.1 North America Dexlansoprazole Delayed-Release Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dexlansoprazole Delayed-Release Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dexlansoprazole Delayed-Release Capsules Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Dexlansoprazole Delayed-Release Capsules Market Size by Type
  2. 9.1.1 Europe Dexlansoprazole Delayed-Release Capsules Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dexlansoprazole Delayed-Release Capsules Sales by Type (2021-2032)
  4. 9.1.3 Europe Dexlansoprazole Delayed-Release Capsules Price by Type (2021-2032)
  5. 9.2 Europe Dexlansoprazole Delayed-Release Capsules Market Size by Application
  6. 9.2.1 Europe Dexlansoprazole Delayed-Release Capsules Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dexlansoprazole Delayed-Release Capsules Sales by Application (2021-2032)
  8. 9.2.3 Europe Dexlansoprazole Delayed-Release Capsules Price by Application (2021-2032)
  9. 9.3 Europe Dexlansoprazole Delayed-Release Capsules Market Size by Country
  10. 9.3.1 Europe Dexlansoprazole Delayed-Release Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dexlansoprazole Delayed-Release Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dexlansoprazole Delayed-Release Capsules Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Dexlansoprazole Delayed-Release Capsules Market Size by Type
  2. 10.1.1 China Dexlansoprazole Delayed-Release Capsules Revenue by Type (2021-2032)
  3. 10.1.2 China Dexlansoprazole Delayed-Release Capsules Sales by Type (2021-2032)
  4. 10.1.3 China Dexlansoprazole Delayed-Release Capsules Price by Type (2021-2032)
  5. 10.2 China Dexlansoprazole Delayed-Release Capsules Market Size by Application
  6. 10.2.1 China Dexlansoprazole Delayed-Release Capsules Revenue by Application (2021-2032)
  7. 10.2.2 China Dexlansoprazole Delayed-Release Capsules Sales by Application (2021-2032)
  8. 10.2.3 China Dexlansoprazole Delayed-Release Capsules Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dexlansoprazole Delayed-Release Capsules Market Size by Type
  2. 11.1.1 Asia Dexlansoprazole Delayed-Release Capsules Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dexlansoprazole Delayed-Release Capsules Sales by Type (2021-2032)
  4. 11.1.3 Asia Dexlansoprazole Delayed-Release Capsules Price by Type (2021-2032)
  5. 11.2 Asia Dexlansoprazole Delayed-Release Capsules Market Size by Application
  6. 11.2.1 Asia Dexlansoprazole Delayed-Release Capsules Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dexlansoprazole Delayed-Release Capsules Sales by Application (2021-2032)
  8. 11.2.3 Asia Dexlansoprazole Delayed-Release Capsules Price by Application (2021-2032)
  9. 11.3 Asia Dexlansoprazole Delayed-Release Capsules Market Size by Country
  10. 11.3.1 Asia Dexlansoprazole Delayed-Release Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dexlansoprazole Delayed-Release Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dexlansoprazole Delayed-Release Capsules Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dexlansoprazole Delayed-Release Capsules Market Size by Type
  2. 12.1.1 SAMEA Dexlansoprazole Delayed-Release Capsules Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dexlansoprazole Delayed-Release Capsules Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dexlansoprazole Delayed-Release Capsules Price by Type (2021-2032)
  5. 12.2 SAMEA Dexlansoprazole Delayed-Release Capsules Market Size by Application
  6. 12.2.1 SAMEA Dexlansoprazole Delayed-Release Capsules Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dexlansoprazole Delayed-Release Capsules Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dexlansoprazole Delayed-Release Capsules Price by Application (2021-2032)
  9. 12.3 SAMEA Dexlansoprazole Delayed-Release Capsules Market Size by Country
  10. 12.3.1 SAMEA Dexlansoprazole Delayed-Release Capsules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dexlansoprazole Delayed-Release Capsules Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dexlansoprazole Delayed-Release Capsules Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dexlansoprazole Delayed-Release Capsules Value Chain Analysis
  2. 13.1.1 Dexlansoprazole Delayed-Release Capsules Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dexlansoprazole Delayed-Release Capsules Production Mode & Process
  6. 13.2 Dexlansoprazole Delayed-Release Capsules Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dexlansoprazole Delayed-Release Capsules Distributors
  9. 13.2.3 Dexlansoprazole Delayed-Release Capsules Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst